Quantcast

Latest Antibiotic-resistant bacteria Stories

2014-08-05 23:01:34

The new products are designed to offer the latest technology at the best prices. Sylmar, CA (PRWEB) August 05, 2014 Kleritec announced today the expansion of their disinfectant and cleaning offerings, in light of recent news from both the FDA and the CDC about antibiotic-resistant bacteria. Among the new products from Kleritec is Medistaph Hand Wipes, Formula 10, and Disinfectant Spray. The Medistaph Wipes protect against MRSA and other antibiotic-resistant bacteria, and can be used for...

2014-08-05 08:32:23

-- Executed Agreement with Evonik for Formulation Development, Analytical Services andClinical Drug Manufacturing -- ROCKVILLE, Md., Aug. 5, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, today announced that, with a new multi-service agreement in place, the Company is on track to initiate Phase Ia and Ib clinical trials of...

2014-08-01 08:26:36

UV disinfection device is game-changer for patients and hospital leaders alike MEMPHIS, Tenn., Aug. 1, 2014 /PRNewswire/ -- Healthcare-associated infections like Methicillin-Resistant Staphylococcus aureus, a bacterium that can cause life-threatening bloodstream infections, pneumonia and surgical site infections, are putting more than patient lives at risk every single day. They're also poised to take big bites out of hospital budgets across the country - to the tune of millions -...

2014-07-31 23:04:04

MRSA has been found to be colonizing people’s homes. Sylmar, CA (PRWEB) July 31, 2014 In a recent article on Salon.com titled “Antibiotic-resistant Superbug MRSA is Now Colonizing People’s Homes,” the author notes that MRSA is not as easily avoidable as once thought, because it’s now found in homes. MRSA is a strain of staph bacteria that is antibiotic-resistant, and, in turn, can be very difficult to treat in patients. MRSA is spread by coming in contact with a person who has...

2014-07-29 12:36:03

ROCKVILLE, Md., July 29, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that in view of the unusual market activity in the Company's stock, the NYSE MKT (the "Exchange") has contacted the Company in accordance with its usual practice. The Company stated that its policy is not to comment on unusual market activity....

2014-07-16 08:29:22

SER-109 demonstrated remarkably high clinical cure rate and excellent safety profile CAMBRIDGE, Mass., July 16, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel treatments for diseases related to the human microbiome, today announced that it has completed enrollment for its single-arm, open-label clinical trial of SER-109, its first-in-field, oral microbiome therapeutic designed for the treatment of recurrent Clostridium difficile Infection...

2014-07-07 16:23:01

LONDON, July 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:MarketVIEW: Clostridium difficile vaccines http://www.reportbuyer.com/pharma_healthcare/therapeutic/marketview_clostridium_difficile_vaccines.htmlClostridium difficile (C.diff) is a Gram-positive bacterium, which in vulnerable hospitalized patients can cause gastrointestinal infections (CDI). Outcomes range from mild uncomplicated diarrhea to severe-complicated disease where patients...

2014-07-07 12:28:56

To Effectively Compete with Current Anti-MRSA Therapies, Emerging Agents Will Need to be Amenable to Outpatient Use, According to Findings from Decision Resources Group BURLINGTON, Mass., July 7, 2014 /PRNewswire/ -- Decision Resources Group finds that, although vancomycin continues to be the standard-of-care for infections caused by methicillin-resistant Staphylococcus aureus (MRSA), there is growing concern among infectious disease (ID) specialists over rising vancomycin minimum inhibitory...

2014-07-07 12:28:38

Company's Breakthrough Innovation to Enable First Therapeutics for Microbiome-based Diseases CAMBRIDGE, Mass., July 7, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel treatments for diseases related to the human microbiome, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pharmaceutical composition patent application that covers its lead product candidate, SER-109, which is currently...

2014-06-30 12:32:12

VANCOUVER, Wash., June 30, 2014 /PRNewswire/ -- SteriWeb Medical has announced FDA over the counter clearance for Omnicide Antimicrobial Gel , a long-lasting, non-antibiotic, petrolatum based topical gel with proven effectiveness against even the most resistant, virulent bacteria, such as MRSA, VRE, and CRE. Laboratory data has also demonstrated complete effectiveness against pathogenic fungi, molds, and yeasts, rendering Omnicide an appropriate choice for a wide variety of clinical...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'